NCT01717027View on ClinicalTrials.gov

Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy
Interventions
DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation A, single dose, taken whole and under fed conditions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation J, single dose, taken whole and under fed conditions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation K, single dose, taken whole and under fed conditions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation J or K, single dose, chewed and under fasted conditions

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pain Therapeutics
All Listed Sponsors
lead

Pain Therapeutics

INDUSTRY

NCT01717027 - Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers | Biotech Hunter | Biotech Hunter